Upstate Active Clinical Trials

Study Title:

Development of Hand-held Biosensors for Rapid Diagnosis and Study of Neural Disease.

What is the purpose of the study?

Researchers at Cornell University are developing a new method to identify Alzheimer’s disease biomarkers. The method has been tested in the laboratory and in an animal model. We now wish to test this technology using blood samples from humans seeking medical attention. If initial results are successful, we hope to develop a hand-held device that will speed up diagnosis by rapidly detecting biomarkers for Alzheimer’s disease.

SUNY Upstate Medical University is working with researchers at Cornell University on this research study. Cornell University investigators are being paid to conduct this study by the SUNY Research Foundation.

We expect about 160 people to provide blood for the Alzheimer’s or memory loss group and about 40 people to provide blood for the control group.

Upstate Institutional Review Board (IRB) Number:


Patient Age Group:


Principal Investigator:

Sharon A Brangman

Who can I contact for more information?

Name: Linda L Spillett, CCRP
Phone: 315-464-8237

Return to Previous Page || Search Again